Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Wound Repair Regen ; 23(5): 672-84, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26080614

ABSTRACT

The custom use of radiotherapy was found to participate in the development of chronic unhealed wounds. In general, exposure to gamma radiation stimulates the production of reactive oxygen species (ROS) that eventually leads to damaging effect. Conversely, overexpression of a nuclear poly (ADP-ribose) polymerase enzyme (PARP) after oxidative insult extremely brings about cellular injury due to excessive consumption of NAD and ATP. Here, we dedicated our study to investigate the role of 3-aminobenzamide (3-AB), a PARP inhibitor, on pregamma irradiated wounds. Two full-thickness (6 mm diameter) wounds were created on the dorsum of Swiss albino mouse. The progression of wound contraction was monitored by capturing daily photo images. Exposure to gamma radiation (6Gy) exacerbated the normal healing of excisional wounds. Remarkably, topical application of 3-AB cream (50 µM) revealed a marked acceleration in the rate of wound contraction. Likewise, PARP inhibition ameliorated the unbalanced oxidative/nitrosative status of granulated skin tissues. Such effect was significantly revealed by the correction of the reduced antioxidant capacity and the enhanced lipid peroxidation, hydrogen peroxide, and myeloperoxidase contents. Moreover, application of 3-AB modified the cutaneous nitrite content throughout healing process. Conversely, the expressions of pro-inflammatory cytokines were down-regulated by PARP inhibition. The mitochondrial ATP content showed a lower consumption rate on 3-AB-treated wound bed as well. In parallel, the mRNA expressions of Sirt-1 and acyl-COA oxidase-2 (ACOX-2) were up-regulated; whom functions control the mitochondrial ATP synthesis and lipid metabolism. The current data suggested that inhibition of PARP-1 enzyme may accelerate the delayed wound healing in whole body gamma irradiated mice by early modifying the oxidative stress as well as the inflammatory response.


Subject(s)
Benzamides/therapeutic use , Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use , Radiation Injuries, Experimental/drug therapy , Skin/metabolism , Wound Healing/drug effects , Animals , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Gamma Rays/adverse effects , Gene Expression Regulation , Immunohistochemistry , Lipid Peroxidation/drug effects , Male , Mice , Mice, Knockout , RNA/administration & dosage , Radiation Injuries, Experimental/metabolism , Radiation Injuries, Experimental/pathology , Real-Time Polymerase Chain Reaction , Skin/drug effects , Skin/radiation effects , Whole-Body Irradiation/adverse effects
2.
Mol Med ; 20: 363-71, 2014 Aug 26.
Article in English | MEDLINE | ID: mdl-25014793

ABSTRACT

Poly(ADP-ribosyl)ation (PARylation) is a protein modification reaction regulating various diverse cellular functions ranging from metabolism, DNA repair and transcription to cell death. We set out to investigate the role of PARylation in wound healing, a highly complex process involving various cellular and humoral factors. We found that topically applied poly[ADP-ribose] polymerase (PARP) inhibitors 3-aminobenzamide and PJ-34 accelerated wound closure in a mouse model of excision wounding. Moreover, wounds also closed faster in PARP-1 knockout mice as compared with wild-type littermates. Immunofluorescent staining for poly(ADP-ribose) (PAR) indicated increased PAR synthesis in scattered cells of the wound bed. Expression of interleukin (IL)-6, tumor necrosis factor (TNF)-α, inducible nitric oxide synthase and matrix metalloproteinase-9 was lower in the wounds of PARP-1 knockout mice as compared with control, and expression of IL-1ß, cyclooxygenase-2, TIMP-1 and -2 also were affected. The level of nitrotyrosine (a marker of nitrating stress) was lower in the wounds of PARP-1 knockout animals as compared with controls. In vitro scratch assays revealed significantly faster migration of keratinocytes treated with 3-aminobenzamide or PJ34 as compared with control cells. These data suggest that PARylation by PARP-1 slows down the wound healing process by increasing the production of inflammatory mediators and nitrating stress and by slowing the migration of keratinocytes.


Subject(s)
Inflammation Mediators/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Wound Healing/physiology , Animals , Cell Movement , Cyclooxygenase 2/genetics , Interleukin-1beta/genetics , Interleukin-6/genetics , Keratinocytes/physiology , Male , Matrix Metalloproteinase 9/genetics , Mice, Inbred BALB C , Mice, Knockout , Nitric Oxide Synthase Type II/genetics , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/genetics , RNA, Messenger/metabolism , Skin/metabolism , Tissue Inhibitor of Metalloproteinase-1/genetics , Tissue Inhibitor of Metalloproteinase-2/genetics , Tumor Necrosis Factor-alpha/genetics
3.
ScientificWorldJournal ; 2014: 731462, 2014.
Article in English | MEDLINE | ID: mdl-24715817

ABSTRACT

In the present study, we investigated the potential beneficial impact of the addition of antioxidant supplements to diclofenac regimen in a model of carrageenan-induced paw. Rats were treated daily with antioxidants, that is, a-lipoic acid (50 mg/kg), selenium (2.5 mg/kg), vitamin C (1 g/kg), vitamin E (300 mg/kg), or zinc (25 mg/kg) on seven successive days and then received a single treatment with diclofenac or saline before carrageenan was injected to induce paw inflammation. The results indicated that these combinations did not significantly affect the percentage inhibition of paw edema caused by diclofenac alone; however, some combination treatments ameliorated signs of concomitant oxidative stress (such as alterations in plasma malondialdehyde (MDA) levels, hemolysate reduced glutathione levels, and erythrocytic superoxide dismutase enzyme activities) imparted by diclofenac alone. In some cases, few tested antioxidants in combination with diclofenac resulted in increased plasma levels of interleukin- (IL-) 6 and C-reactive protein (CRP). In conclusion, the results of these studies suggested to us that the added presence of natural antioxidants could be beneficial as standard anti-inflammatory therapeutics for a patient under diclofenac treatment, albeit that these effects do not appear to significantly build upon those that could be obtained from this common anti-inflammatory agent per se.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Diclofenac/pharmacology , Animals , Male , Rats , Rats, Sprague-Dawley
4.
Photodiagnosis Photodyn Ther ; 11(2): 239-49, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24632333

ABSTRACT

BACKGROUND: Indocyanine green (ICG) is a promising water-soluble photosensitizer for photodynamic therapy (PDT) of tumors. It was reported to have promising phototoxic effect on different cell lines. This study aimed to evaluate the efficacy of ICG as an efficient PS agent for skin cancer induced in mice. METHODS: Skin squamous cell carcinoma was induced in female CD-1 mice by 7,12-dimethylbenzanthracene and 12-O-tetradecanoyl-phorbol-13-acetate followed by an ICG/PDT treatment. The laser irradiation for PDT was adjusted to cover the whole body of the mice to make sure that the treatment protocol will be delivered to multiple tumors. RESULTS: The treatment of skin cancer by ICG/PDT using intravenously injected ICG initiated tumor cell death and significantly decreased cell proliferation as indicated by the reduction in proliferating cell nuclear antigen positivity. A significant reduction in the inflammatory mediators; tumor necrosis factor-α, nitric oxide and 5-lipoxygenase was reported, however the level of cyclooxygenase-2 (COX-2) was significantly elevated after ICG/PDT treatment. CONCLUSION: The proposed ICG/PDT treatment modality showed a significant anti-tumor and anti-inflammatory activity against skin cancer accompanied with COX-2 elevation.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Dermatitis/drug therapy , Indocyanine Green/therapeutic use , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , Skin Neoplasms/drug therapy , Animals , Carcinoma, Squamous Cell/immunology , Cytokines/immunology , Dermatitis/immunology , Female , Mice , Skin Neoplasms/immunology , Treatment Outcome
5.
Pharmacol Res ; 46(3): 273-9, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12220971

ABSTRACT

Oxidative stress is believed to be implicated in the pathogenesis of postischaemic cerebral injury. Many antioxidants were shown to be neuroprotective in experimental models of cerebral ischaemia/reperfusion (I/R). The present study was designed to investigate the potential protective effects of curcumin (CUR) against I/R insult in rat forebrain. The model adopted was that of surgically-induced forebrain ischaemia, performed by means of bilateral common carotid artery occlusion (BCCAO) for 1 h, followed by reperfusion for another 1h. The effects of a single i.p. dose of CUR (50, 100 or 200 mg kg(-1)), administered 0.5 h after the onset of ischaemia, were investigated by assessing oxidative stress-related biochemical parameters in rat forebrain. CUR, at the highest dose level (200 mg kg(-1)), decreased the I/R-induced elevated xanthine oxidase (XO) activity, superoxide anion (O(2)*(-)) production, malondialdehyde (MDA) level and glutathione peroxidase (GPx), superoxide dismutase (SOD), and lactate dehydrogenase (LDH) activities. On the other hand, CUR did not affect the declined reduced glutathione (GSH) content due to I/R insult. Worth mentioning is that the activity of catalase (CAT) did not change in response to either I/R insult or drug treatment. In conclusion, CUR was found to protect rat forebrain against I/R insult. These protective effects may be attributed to its antioxidant properties and/or its inhibitory effects on xanthine dehydrogenase/xanthine oxidase (XD/XO) conversion and resultant O(2)*(-) production.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Brain Ischemia/prevention & control , Curcumin/therapeutic use , Prosencephalon/drug effects , Reperfusion Injury/prevention & control , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/pharmacology , Antioxidants/therapeutic use , Brain Ischemia/metabolism , Catalase/drug effects , Catalase/metabolism , Curcumin/pharmacology , Glutathione Peroxidase/drug effects , Glutathione Peroxidase/metabolism , L-Lactate Dehydrogenase/drug effects , L-Lactate Dehydrogenase/metabolism , Male , Malondialdehyde/metabolism , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Prosencephalon/metabolism , Prosencephalon/pathology , Rats , Rats, Sprague-Dawley , Reperfusion Injury/metabolism , Superoxide Dismutase/drug effects , Superoxide Dismutase/metabolism , Superoxides/metabolism , Xanthine Oxidase/drug effects , Xanthine Oxidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...